Antigenics seeks EU marketing nod for kidney cancer drug Oncophage
Friday, October 24, 2008 11:00 IST New York
Antigenics Inc announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) requesting approval for Oncophage in earlier-stage